1p36.22 region containing PGD gene is frequently gained in human cervical cancer

Maria Lee, Eun Sook Nam, Seung Hyun Jung, Soon Young Kim, Sung Jong Lee, Joo Hee Yoon, Nak Woo Lee, Seob Jeon, Joong Sub Choi, Chi Heum Cho, Yong Moon, Yeun Jun Chung, Yongil Kwon

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aim: To identify commonly occurring DNA copy number alterations in Korean cervical cancers. Methods: DNA copy number alteration was screened by whole-genome array comparative genomic hybridization (CGH) analysis. For the array CGH discovery, genomic DNA from five cervical cancers and 10 normal cervical tissues were examined. For the independent validation of the most significant chromosomal alteration (1p36.22, PGD gene), 40 formalin-fixed paraffin-embedded cervical tissue samples were collected; 10 of them were used for quantitative polymerase chain reaction and the other 30 samples were used for immunohistochemical analysis. Chromosomal segments differently distributed between cancers and normal controls were determined to be recurrently altered regions (RAR). Results: A total of 13 RAR (11 RAR losses and two RAR gains) were defined in this study. Of the 13 cervical cancer-specific RAR, RAR gain in the 1p36.22 locus where the PGD gene is located was the most commonly detected in cancers (P = 0.004). In the quantitative polymerase chain reaction replication, copy number gain of the PGD gene was consistently identified in cervical cancers but not in the normal tissues (P = 0.02). In immunohistochemical analysis, PGD expression was significantly higher in cervical cancers than normal tissues (P = 0.02). Conclusion: Our results will be helpful to understand cervical carcinogenesis, and the PGD gene can be a useful biomarker of cervical cancer.

Original languageEnglish
Pages (from-to)545-553
Number of pages9
JournalJournal of Obstetrics and Gynaecology Research
Volume40
Issue number2
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Prostaglandins D
Uterine Cervical Neoplasms
Genes
Comparative Genomic Hybridization
DNA
Polymerase Chain Reaction
Paraffin
Formaldehyde
Neoplasms
Carcinogenesis
Biomarkers
Genome

Keywords

  • Array comparative genomic hybridization
  • Cervical cancer
  • Copy number alteration
  • PGD
  • Recurrently altered region

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Lee, M., Nam, E. S., Jung, S. H., Kim, S. Y., Lee, S. J., Yoon, J. H., ... Kwon, Y. (2014). 1p36.22 region containing PGD gene is frequently gained in human cervical cancer. Journal of Obstetrics and Gynaecology Research, 40(2), 545-553. https://doi.org/10.1111/jog.12193

1p36.22 region containing PGD gene is frequently gained in human cervical cancer. / Lee, Maria; Nam, Eun Sook; Jung, Seung Hyun; Kim, Soon Young; Lee, Sung Jong; Yoon, Joo Hee; Lee, Nak Woo; Jeon, Seob; Choi, Joong Sub; Cho, Chi Heum; Moon, Yong; Chung, Yeun Jun; Kwon, Yongil.

In: Journal of Obstetrics and Gynaecology Research, Vol. 40, No. 2, 01.01.2014, p. 545-553.

Research output: Contribution to journalArticle

Lee, M, Nam, ES, Jung, SH, Kim, SY, Lee, SJ, Yoon, JH, Lee, NW, Jeon, S, Choi, JS, Cho, CH, Moon, Y, Chung, YJ & Kwon, Y 2014, '1p36.22 region containing PGD gene is frequently gained in human cervical cancer', Journal of Obstetrics and Gynaecology Research, vol. 40, no. 2, pp. 545-553. https://doi.org/10.1111/jog.12193
Lee, Maria ; Nam, Eun Sook ; Jung, Seung Hyun ; Kim, Soon Young ; Lee, Sung Jong ; Yoon, Joo Hee ; Lee, Nak Woo ; Jeon, Seob ; Choi, Joong Sub ; Cho, Chi Heum ; Moon, Yong ; Chung, Yeun Jun ; Kwon, Yongil. / 1p36.22 region containing PGD gene is frequently gained in human cervical cancer. In: Journal of Obstetrics and Gynaecology Research. 2014 ; Vol. 40, No. 2. pp. 545-553.
@article{721dc6bde3bb4f97a80a1a93c83c091f,
title = "1p36.22 region containing PGD gene is frequently gained in human cervical cancer",
abstract = "Aim: To identify commonly occurring DNA copy number alterations in Korean cervical cancers. Methods: DNA copy number alteration was screened by whole-genome array comparative genomic hybridization (CGH) analysis. For the array CGH discovery, genomic DNA from five cervical cancers and 10 normal cervical tissues were examined. For the independent validation of the most significant chromosomal alteration (1p36.22, PGD gene), 40 formalin-fixed paraffin-embedded cervical tissue samples were collected; 10 of them were used for quantitative polymerase chain reaction and the other 30 samples were used for immunohistochemical analysis. Chromosomal segments differently distributed between cancers and normal controls were determined to be recurrently altered regions (RAR). Results: A total of 13 RAR (11 RAR losses and two RAR gains) were defined in this study. Of the 13 cervical cancer-specific RAR, RAR gain in the 1p36.22 locus where the PGD gene is located was the most commonly detected in cancers (P = 0.004). In the quantitative polymerase chain reaction replication, copy number gain of the PGD gene was consistently identified in cervical cancers but not in the normal tissues (P = 0.02). In immunohistochemical analysis, PGD expression was significantly higher in cervical cancers than normal tissues (P = 0.02). Conclusion: Our results will be helpful to understand cervical carcinogenesis, and the PGD gene can be a useful biomarker of cervical cancer.",
keywords = "Array comparative genomic hybridization, Cervical cancer, Copy number alteration, PGD, Recurrently altered region",
author = "Maria Lee and Nam, {Eun Sook} and Jung, {Seung Hyun} and Kim, {Soon Young} and Lee, {Sung Jong} and Yoon, {Joo Hee} and Lee, {Nak Woo} and Seob Jeon and Choi, {Joong Sub} and Cho, {Chi Heum} and Yong Moon and Chung, {Yeun Jun} and Yongil Kwon",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/jog.12193",
language = "English",
volume = "40",
pages = "545--553",
journal = "Journal of Obstetrics and Gynaecology Research",
issn = "1341-8076",
publisher = "Blackwell Publishing Asia",
number = "2",

}

TY - JOUR

T1 - 1p36.22 region containing PGD gene is frequently gained in human cervical cancer

AU - Lee, Maria

AU - Nam, Eun Sook

AU - Jung, Seung Hyun

AU - Kim, Soon Young

AU - Lee, Sung Jong

AU - Yoon, Joo Hee

AU - Lee, Nak Woo

AU - Jeon, Seob

AU - Choi, Joong Sub

AU - Cho, Chi Heum

AU - Moon, Yong

AU - Chung, Yeun Jun

AU - Kwon, Yongil

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Aim: To identify commonly occurring DNA copy number alterations in Korean cervical cancers. Methods: DNA copy number alteration was screened by whole-genome array comparative genomic hybridization (CGH) analysis. For the array CGH discovery, genomic DNA from five cervical cancers and 10 normal cervical tissues were examined. For the independent validation of the most significant chromosomal alteration (1p36.22, PGD gene), 40 formalin-fixed paraffin-embedded cervical tissue samples were collected; 10 of them were used for quantitative polymerase chain reaction and the other 30 samples were used for immunohistochemical analysis. Chromosomal segments differently distributed between cancers and normal controls were determined to be recurrently altered regions (RAR). Results: A total of 13 RAR (11 RAR losses and two RAR gains) were defined in this study. Of the 13 cervical cancer-specific RAR, RAR gain in the 1p36.22 locus where the PGD gene is located was the most commonly detected in cancers (P = 0.004). In the quantitative polymerase chain reaction replication, copy number gain of the PGD gene was consistently identified in cervical cancers but not in the normal tissues (P = 0.02). In immunohistochemical analysis, PGD expression was significantly higher in cervical cancers than normal tissues (P = 0.02). Conclusion: Our results will be helpful to understand cervical carcinogenesis, and the PGD gene can be a useful biomarker of cervical cancer.

AB - Aim: To identify commonly occurring DNA copy number alterations in Korean cervical cancers. Methods: DNA copy number alteration was screened by whole-genome array comparative genomic hybridization (CGH) analysis. For the array CGH discovery, genomic DNA from five cervical cancers and 10 normal cervical tissues were examined. For the independent validation of the most significant chromosomal alteration (1p36.22, PGD gene), 40 formalin-fixed paraffin-embedded cervical tissue samples were collected; 10 of them were used for quantitative polymerase chain reaction and the other 30 samples were used for immunohistochemical analysis. Chromosomal segments differently distributed between cancers and normal controls were determined to be recurrently altered regions (RAR). Results: A total of 13 RAR (11 RAR losses and two RAR gains) were defined in this study. Of the 13 cervical cancer-specific RAR, RAR gain in the 1p36.22 locus where the PGD gene is located was the most commonly detected in cancers (P = 0.004). In the quantitative polymerase chain reaction replication, copy number gain of the PGD gene was consistently identified in cervical cancers but not in the normal tissues (P = 0.02). In immunohistochemical analysis, PGD expression was significantly higher in cervical cancers than normal tissues (P = 0.02). Conclusion: Our results will be helpful to understand cervical carcinogenesis, and the PGD gene can be a useful biomarker of cervical cancer.

KW - Array comparative genomic hybridization

KW - Cervical cancer

KW - Copy number alteration

KW - PGD

KW - Recurrently altered region

UR - http://www.scopus.com/inward/record.url?scp=84897978996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897978996&partnerID=8YFLogxK

U2 - 10.1111/jog.12193

DO - 10.1111/jog.12193

M3 - Article

VL - 40

SP - 545

EP - 553

JO - Journal of Obstetrics and Gynaecology Research

JF - Journal of Obstetrics and Gynaecology Research

SN - 1341-8076

IS - 2

ER -